Mortality Risks Associated with Elective Atrial Fibrillation Ablation Procedures in Japan
By
Koichi Inoue
Koshiro Kanaoka
Yasunori Ueda
Haruhiko Abe
Kuniyasu Ikeoka
Tsuyoshi Mishima
Tatsuhisa Ozaki
Takuya Ohashi
Satoshi Osaki
Yoko Sumita
Yoshitaka Iwanaga
Yasushi Matsumura
Yasushi Sakata
August 29, 2026
Clinical Scorecard: Mortality Risks Associated with Elective Atrial Fibrillation Ablation Procedures in Japan
At a Glance
Category Detail
Condition Atrial Fibrillation Ablation Key Mechanisms Elective invasive intervention aimed at symptom relief and quality of life enhancement. Target Population Patients undergoing elective atrial fibrillation ablation procedures in Japan. Care Setting Cardiovascular centers and community hospitals in Japan.
Key Highlights
Mortality estimates for AF ablation vary significantly, ranging from 0.05% to 0.46%. The JROAD-DPC database provides a reliable framework for assessing periprocedural mortality. High-volume hospitals report lower in-hospital mortality rates compared to lower-volume centers. The study focuses on elective AF ablation, excluding emergent procedures. 30-day mortality measures exclude deaths occurring outside the treating hospital. Guideline-Based Recommendations
Diagnosis
Utilize the JROAD-DPC database for accurate identification of elective AF ablation cases. Management
Prioritize high-volume centers for elective AF ablation to minimize mortality risks. Monitoring & Follow-up
Monitor for unplanned readmissions and major complications within 30 days post-procedure. Risks
Consider the potential for higher mortality rates associated with lower-volume centers. Patient & Prescribing Data
Patients undergoing elective catheter ablation for atrial fibrillation.
Focus on scheduled hospitalizations with validated admission and discharge outcomes.
Clinical Best Practices
Ensure rigorous validation of admission status and discharge outcomes. Adhere to the STROBE guidelines for observational studies in reporting. Related Resources & Content
